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OBJECTIVE This study was designed to evaluate the prognostic value of heart rate variability for sudden
death, resuscitated ventricular fibrillation or sustained ventricular tachycardia in patients with
idiopathic dilated cardiomyopathy.
BACKGROUND Previous studies have shown that heart rate variability could predict arrhythmic events and
sudden death in postinfarction patients, but the prognostic value of heart rate variability for
arrhythmic events or sudden death in patients with idiopathic dilated cardiomyopathy has not
been established.
METHODS Time and frequency domain analysis of heart rate variability on 24-h electrocardiographic
(ECG) recording was assessed in 116 patients with idiopathic dilated cardiomyopathy (91
men, aged 51 6 12 years, left ventricular ejection fraction 34 6 12%).
RESULTS Mean follow-up (6 SD) was 53 6 39 months. Sixteen patients reached one of the defined
study end-points (sudden death, resuscitated ventricular fibrillation or sustained ventricular
tachycardia) during follow-up. Using multivariate analysis, only reduced standard deviation of
all normal-to-normal intervals (SDNN) (p 5 0.02) and ventricular tachycardia during 24-h
ECG recording (p 5 0.02) predicted sudden death and/or arrhythmic events. For SDNN, a
cutoff level of 100 ms seemed the best for the risk stratification.
CONCLUSIONS Decrease in heart rate variability is an independent predictor of arrhythmic events and sudden
death in idiopathic dilated cardiomyopathy, whether the mechanism of sudden death is
ventricular tachyarrhythmia or not. (J Am Coll Cardiol 1999;33:1203–7) © 1999 by the
American College of Cardiology
Imbalanced regulation of the cardiac autonomic nervous
system is one of the important pathophysiological changes
in congestive heart failure, and analysis of heart rate vari-
ability (HRV) provides information about these distur-
bances. Several studies have shown that a decrease in HRV
is associated with poor prognosis after acute myocardial
infarction (1–4). Decreased HRV has been related to the
risk of ventricular arrhythmias and of sudden death (1,3,4).
We investigated the prognostic value of HRV for sudden
death and arrhythmic events (resuscitated ventricular fibril-
lation or sustained ventricular tachycardia) in patients with
idiopathic dilated cardiomyopathy (IDC), a population in
whom this element has not previously been demonstrated.
METHODS
Patients. One hundred and forty patients with IDC ac-
cording to the definitions of the World Health Organiza-
tion (5) were continuously studied between February 1983
and June 1998. Diagnosis was established by normal coro-
nary angiography in all patients, echocardiography and
radionuclide-gated blood pool ventriculography. Patients
with chronic renal failure, diabetes mellitus, atrial arrhyth-
mias, sinus node dysfunction, atrioventricular block or with
a permanent pacemaker were excluded for analysis of HRV.
Analysis of HRV was possible in 116 patients. At the time
of the 24-h ambulatory electrocardiographic (ECG) record-
ing, patients were treated with diuretics (47%), digoxin
(45%), angiotensin-converting enzyme (ACE) inhibitors
(45%), and/or nitrates (14%). Because they were seen at the
time of the diagnosis of disease, 36% of the patients were
not receiving medical treatment. None of the patients were
receiving beta-blockers or antiarrhythmic agents. All the
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patients were treated during follow-up with long-term ACE
inhibition, and/or diuretics or digoxin if necessary.
24-h ambulatory ECG recording. Twenty-four hour am-
bulatory ECG recording was performed by a two-channel
recorder. All recordings were analyzed using an HRV
system (Medilog Excel 5-1; Oxford) with manual edition
and correction of RR intervals and QRS. Tapes were
eligible if they had at least 20 h of analyzable data.
Ventricular arrhythmias were classified according to Lown’s
grades, and nonsustained ventricular tachycardia was de-
fined as three or more consecutive premature ventricular
beats, each lasting less than 30 s (6).
The time domain analysis of HRV included Mean RR
(mean duration of all normal-to-normal [NN] intervals,
ms), SDNN (standard deviation of all NN intervals, ms),
SDANN (standard deviation of the averages of NN inter-
vals in all 5-min segments, ms), rmsSD (square root of the
sum of the squares of differences between adjacent NN
intervals, ms) and pNN50 (number of NN intervals differ-
ing by more than 50 ms from adjacent interval divided by
the total number of all NN intervals, %).
The spectral analysis algorithm used a fast Fourier trans-
form. Data were analyzed in 10-min epochs throughout the
recording. The results from each 10-min epoch were aver-
aged to form a composite spectrum. The range 0 to 0.5 Hz
was represented by 1,000 harmonics. The data were pre-
sented in a nonlinear scale (ms2). Frequency domain mea-
surements included: total power (Tot P: 0–0.4 Hz), very
low frequency (VLF: 0.0033–0.04 Hz), low frequency (LF:
0.04–0.15 Hz) and high frequency (HF: 0.15–0.4 Hz).
Statistical analysis. The power spectral measures were
transformed in natural logarithms (ln) to achieve normal
distributions. Event-free curves were estimated by the
Kaplan-Meier method, and curves were compared with the
log rank test. Sudden death was defined as instantaneous
death or death occurring within 1 h of the onset of
symptoms in a patient without evidence of the presence of
progressive heart failure or death during sleep (7). The
effects of hemodynamic parameters, HRV and runs of
ventricular tachycardia were studied with univariate analysis
and multivariate regression analysis (proportional hazards
model). A forward stepwise model with a p value for entry
of 0.05 was used. All values are given as mean 6 standard
deviation. Statview 4.5 software (Abacus Concepts) was
used for statistical analysis.
RESULTS
Characteristics of patients. The mean age of the patients
on hospital admission was 51 6 12 years (range 21 to 70).
Ninety-one (78%) were men. Clinical data and results of
ECG, radionuclide ventriculography, hemodynamic inves-
tigations and 24-h ambulatory ECG are summarized in
Table 1. Measurements of HRV are in Table 2.
Analysis of mortality and cardiac events. Mean follow-up
was 53 6 39 months. Eighteen patients died during
follow-up: nine progressive congestive heart failure (CHF),
seven sudden deaths and two noncardiac deaths (cancer).
Four patients could be resuscitated from documented ven-
tricular fibrillation (VF) and 6 more patients had sustained
ventricular tachycardia (VT). Of these 10 patients, seven
were treated with an implantable cardioverter-defibrillator,
one was treated with sotalol and had no recurrence, one
underwent heart transplantation and the last one was treated
Abbreviations and Acronyms
CHF 5 congestive heart failure
ECG 5 electrocardiogram
HF 5 high frequency power
HRV 5 heart rate variability
IDC 5 idiopathic dilated cardiomyopathy
LF 5 low frequency power
LV 5 left ventricle
Mean RR 5 mean duration of all normal-to-normal
NN 5 normal-to-normal intervals
NYHA class 5 New York Heart Association function
class
pNN50 5 number of NN intervals differing by
more than 50 ms from adjacent interval
divided by the total number of all NN
intervals
rmsSD 5 square root of the sum of the squares of
differences between adjacent NN
intervals
SDANN 5 standard deviation of the averages of
NN intervals in all 5-min segments
SDNN 5 standard deviation of all NN intervals
Tot P 5 total frequency power
VLF 5 very low frequency power
VF 5 ventricular fibrillation
VT 5 ventricular tachycardia
Table 1. Clinical Characteristics and Results of Investigations in
Patients With IDC
Age (years) 51 6 12
Gender (M/F) 92/24
NYHA class:
I–II n (%) 66 (57%)
III–IV n (%) 50 (43%)
Duration of heart failure symptoms (months) 23 6 35
Left bundle branch block n (%) 35 (30%)
LV end diastolic diameter (mm) 67 6 9
LV end systolic diameter (mm) 54 6 11
LV shortening fraction (%) 20 6 9
Mean pulmonary artery pressure (mm Hg) 19 6 9
Pulmonary capillary wedge pressure (mm Hg) 13 6 8
Cardiac index (liters/min/m2) 2.95 6 0.8
LV ejection fraction (%) 34 6 12
Lown 4B on ambulatory 24-h ECG n (%) 36 (31%)
LV 5 left ventricle; NYHA class 5 New York Heart Association function class.
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with amiodarone but had poor therapy compliance and
suffered sudden death. Eleven patients underwent heart
transplantation and were censored at the time of the
transplantation for statistical analysis of survival. After
follow-up, 16 patients reached one of the prospectively
defined study end-points (sudden death, resuscitated VF or
sustained VT). The event-free curves of cardiac deaths
(CHF or sudden death), of sudden death alone and of
arrhythmic events (resuscitated VF or spontaneous sus-
tained VT) are shown in Figure 1.
Main characteristics and measurements of HRV in pa-
tients with sudden death, arrhythmic events or free of events
are in Table 3. Statistical analysis was not performed on
these data because a t test would not take into account the
duration of the follow-up. Univariate regression analysis
demonstrated that nonsustained ventricular tachycardia on
24-h ambulatory ECG recording (p 5 0.01), decreased
SDNN (p 5 0.02), decreased Tot P (p 5 0.04) and
decreased VLF (p 5 0.04) were predictors of sudden death
and/or arrhythmic events. Age, New York Heart Associa-
tion function (NYHA) class, left ventricular ejection frac-
tion and other hemodynamic parameters were not predic-
tors of end-point. When univariate predictors were included
in the multivariate analysis, only reduced SDNN (p 5 0.02)
and ventricular tachycardia during 24-h ECG recording
(p 5 0.02) were independent predictors of sudden death
and/or arrhythmic events.
Event-free curves for total patients according to SDNN
are displayed in Figure 2 for cardiac death and in Figure 3
for sudden death and/or arrhythmic events. One patient
with arrhythmic event suffered sudden death and was
plotted with the follow-up at the time he had sustained VT
on the event-free curves of sudden death and/or arrhythmic
events. For SDNN, we used a cutoff level of 100 ms as used
in previous studies concerning HRV in congestive heart
Table 2. Time-Domain and Frequency-Domain Measurements
of HRV on 24-h Ambulatory ECG in Patients With IDC
Mean RR (ms) 740 6 128
SDNN (ms) 97 6 39
SDANN (ms) 84 6 18
rmsSD (ms) 25 6 14
pNN50 (%) 5.8 6 7.6
ln Tot P (ln ms2) 7.5 6 1.0
ln VLF (ln ms2) 3.4 6 0.5
ln LF (ln ms2) 5.5 6 1.2
ln HF (ln ms2) 4.4 6 1.0
HF 5 high frequency power; LF 5 low frequency power; ln 5 natural logarithm;
Mean RR 5 mean duration of all normal-to-normal (NN) intervals; pNN50 5
number of NN intervals differing by more than 50 ms from adjacent interval divided
by the total number of all NN intervals; rmsSD 5 square root of the mean of the sum
of the squares of differences between adjacent NN intervals; SDANN 5 standard
deviation of the averages of NN intervals in all 5-min segments; SDNN 5 standard
deviation of all NN intervals; Tot P 5 total frequency power; VLF 5 very low
frequency power.
Figure 1. Event-free curves of cardiac deaths, sudden deaths and
arrhythmic events (resuscitated ventricular fibrillation or sponta-
neous sustained ventricular tachycardia) in patients with idiopathic
dilated cardiomyopathy.
Table 3. Characteristics, Time-Domain and Frequency-Domain
Measurements of HRV on 24-h Ambulatory ECG in Patients
With Sudden Death, Arrhythmic Events or Free of Event
Free of
Event
(n 5 100)
Sudden
Death
(n 5 7)
Arrhythmic
Event
(n 5 10)
Age (yrs) 51 6 12 50 6 12 53 6 15
Duration of FU (months) 53 6 41 31 6 24 37 6 9
LVEF (%) 35 6 13 34 6 9 37 6 9
Mean RR (ms) 727 6 119 717 6 87 778 6 167
SDNN (ms) 101 6 39 69 6 24 80 6 27
SDANN (ms) 84 6 17 80 6 11 85 6 12
rmsSD (ms) 25 6 15 29 6 12 25 6 8
pNN50 (%) 5.7 6 7.8 9.4 6 6.3 5.3 6 4.7
ln Tot P (ln ms2) 7.6 6 1.0 6.9 6 1.2 7.1 6 1.0
ln VLF (ln ms2) 3.5 6 0.5 3.0 6 0.6 3.2 6 0.5
ln LF (ln ms2) 5.6 6 1.2 4.9 6 1.3 5.0 6 1.2
ln HF (ln ms2) 4.4 6 1.0 4.4 6 1.1 4.3 6 0.9
FU 5 follow-up; other abbreviations as in Table 2. Data of one patient with
arrhythmic event who suffered sudden death are included both in column 2 and in
column 3.
Figure 2. Event-free curves of cardiac death (progressive conges-
tive heart failure or sudden death) according to standard deviation
of all normal-to-normal intervals in patients with idiopathic
dilated cardiomyopathy.
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failure (8,9), and it was possible to determine two groups of
patients with significantly different event-free curves of
cardiac death (p 5 0.002) and event-free curves of sudden
death and/or arrhythmic event (p 5 0.03).
DISCUSSION
To the best of our knowledge, this study is the first to show
that decreased SDNN is an independent predictor of
sudden death, resuscitated VF or sustained VT in idiopathic
dilated cardiomyopathy (IDC) and to suggest that HRV is
a method for stratification of major arrhythmic events in
CHF without coronary artery disease. Moreover, it was
confirmed that a low SDNN was also a predictor of cardiac
mortality of all causes in patients with IDC.
Spectral analysis of HRV was performed in all patients
but it provided only redundant information at the time of
multivariate statistical analysis. It is well known that the
results of frequency-domain analysis are equivalent to those
of time-domain analysis, which is easier to perform (1),
particularly for SDNN. It should be noticed that total power
had less power than SDNN after multiregression, whereas
these two parameters give similar information about overall
HRV from a theoretical point of view. The technical
explanation might be that total power in this study was the
average of the total power of each 10-min period. It thus
excludes the ultra-low-frequency power of HRV, a possible
predictor of mortality. However, we give the results of the
spectral analysis, because Bigger et al. found that the
very-low-frequency power after myocardial infarction was
more strongly associated with arrhythmic death than with
all-cause mortality or cardiac death (3), although the phys-
iological mechanisms for this component has not been fully
identified. Moreover, a recent study by Mortara et al.
suggested that breathing disorders are not uncommon in
congestive heart failure, and they are associated with an
increase in the VLF power that can affect measurement of
HRV (10). It was found that VLF accounted for 55% of
total HRV in subjects with normal breathing, whereas VLF
was 77% and 87% of Tot P in patients with periodic
breathing or Cheyne-Stokes respiration, respectively. In our
study, the ratio of VLF to Tot P was 53% for the whole
group; it was also 53% in patients who suffered sudden
death and 54% in patients with arrhythmic events, thus
similar to subjects with normal breathing in the study by
Mortara. It appears, therefore, that our study was not
affected by this confounding effect.
Hoffmann et al. had already evaluated HRV in 71
patients with IDC and major arrhythmic events (sustained
VT, VF and sudden death) (11). With a relatively short
follow-up of 15 6 5 months, they found a nonsignificant
trend toward lower parasympathetic activity in the time-
domain in patients with major arrhythmic events. In this
study, as in most others, sudden death was considered to be
an arrhythmic event, due to ventricular tachyarrhythmias.
However, the incidence of cerebral or pulmonary embolism,
severe bradycardia or electromechanical dissociation is prob-
ably underestimated in patients with advanced heart failure
(12).
There is a high incidence of spontaneous ventricular
arrhythmias during 24-h ambulatory ECG in patients with
IDC, but the prognostic value of these abnormalities for
sudden death remains controversial (13–15). The value of
signal-averaged ECG is limited by frequent bundle branch
block in patients with IDC. Moreover, this method only
explores the possible re-entrant substrate for ventricular
arrhythmias, and has a controversial prognostic value for
sudden death in IDC (14,15). Electrophysiological testing
has a poor negative predictive value for sudden death in
IDC (15). QT dispersion, a measurement of the inhomo-
geneity of myocardial repolarization that could in some
cases be a marker of arrhythmic events when abnormally
increased, has not been shown to be a predictor of death or
arrhythmic events in IDC (16). Negative results with these
three methods of investigation are further arguments, sug-
gesting that ventricular tachyarrhythmias could be only one
of the several mechanisms of sudden death in IDC. De-
crease in HRV might be a predictor of both “arrhythmic”
and “nonarrhythmic” sudden death in IDC.
In a previous study concerning the general characteristics
of HRV in IDC, we found that analysis of HRV in
association with hemodynamic parameters allows better
identification of patients at high risk of cardiac death or
heart transplantation but that there was no correlation
between HRV and ventricular arrhythmias or signal-
averaged ECG in patients with IDC (9). Sudden death was
the cause of only 35% of deaths in both studies. Hence, our
results provide new information about the prognostic value
of HRV in IDC in comparison with the previous study. Our
results do not contradict the hypothesis that a decrease in
HRV is mainly a reflection of the deterioration in hemo-
dynamic status, as previously described in CHF (17).
Not all patients in this study had the same treatment at
the time of the ambulatory ECG recording. It is known that
Figure 3. Event-free curves of sudden death and arrhythmic events
according to standard deviation of all normal-to-normal intervals
in patients with idiopathic dilated cardiomyopathy.
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ACE inhibition and digoxin affect heart rate variability
(18–21). However, the groups of patients with sudden
death, arrhythmic events or free of events did not differ in
their medical treatment at this time, and they were there-
after treated with a similar standard treatment for chronic
heart failure. Whether an increase in SDNN with medical
treatment may reverse the poor prognosis of patients with
decreased SDNN should be investigated in the future.
Conclusions. This study is one of the first to show that
HRV provides a stratification of sudden death and/or major
arrhythmic events in CHF without coronary artery disease.
Our results, which were obtained in a relatively large group
of patients with long follow-up, indicate that reduction in
SDNN is an independent prognostic marker of these events
in IDC, whether the mechanism of sudden death is ven-
tricular tachyarrhythmia or not.
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